- Home
- PAYO vs AMRX Comparison
PAYO vs AMRX Comparison
Compare PAYO & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAYO
- AMRX
- Stock Information
- Founded
- PAYO 2005
- AMRX 2002
- Country
- PAYO United States
- AMRX United States
- Employees
- PAYO N/A
- AMRX N/A
- Industry
- PAYO EDP Services
- AMRX Biotechnology: Pharmaceutical Preparations
- Sector
- PAYO Technology
- AMRX Health Care
- Exchange
- PAYO Nasdaq
- AMRX Nasdaq
- Market Cap
- PAYO 2.7B
- AMRX 2.9B
- IPO Year
- PAYO N/A
- AMRX N/A
- Fundamental
- Price
- PAYO $6.48
- AMRX $9.79
- Analyst Decision
- PAYO Strong Buy
- AMRX Strong Buy
- Analyst Count
- PAYO 8
- AMRX 4
- Target Price
- PAYO $10.06
- AMRX $11.50
- AVG Volume (30 Days)
- PAYO 2.6M
- AMRX 1.5M
- Earning Date
- PAYO 11-04-2025
- AMRX 11-07-2025
- Dividend Yield
- PAYO N/A
- AMRX N/A
- EPS Growth
- PAYO N/A
- AMRX N/A
- EPS
- PAYO 0.25
- AMRX 0.01
- Revenue
- PAYO $1,017,244,000.00
- AMRX $2,852,914,000.00
- Revenue This Year
- PAYO $9.64
- AMRX $9.56
- Revenue Next Year
- PAYO $7.65
- AMRX $6.27
- P/E Ratio
- PAYO $25.89
- AMRX $911.06
- Revenue Growth
- PAYO 13.02
- AMRX 9.81
- 52 Week Low
- PAYO $5.71
- AMRX $6.69
- 52 Week High
- PAYO $11.29
- AMRX $10.34
- Technical
- Relative Strength Index (RSI)
- PAYO 43.28
- AMRX 62.50
- Support Level
- PAYO $6.44
- AMRX $9.32
- Resistance Level
- PAYO $6.87
- AMRX $10.34
- Average True Range (ATR)
- PAYO 0.19
- AMRX 0.24
- MACD
- PAYO -0.03
- AMRX -0.01
- Stochastic Oscillator
- PAYO 6.50
- AMRX 51.75
About PAYO Payoneer Global Inc.
Payoneer Global Inc is a financial technology company purpose-built to enable the world's small and medium-sized businesses (SMB(s)) to grow and operate their businesses around the world by reliably and securely connecting them to the digital economy. The company started to empower commerce by connecting businesses, professionals, countries, and currencies with its diversified cross-border payments platform.
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.